Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03537599
What this trial is testing

Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant

Who this might be right for
Minimal Residual DiseaseRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesRecurrent Adult Acute Myeloid Leukemia+1 more
Sumithira Vasu 4
Testing effectiveness (Phase 2)Study completedNCT00005801
What this trial is testing

Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
University of Colorado, Denver
Large-scale testing (Phase 3)Looking for participantsNCT07387367
What this trial is testing

Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

Who this might be right for
Adenovirus Infections
SymBio Pharmaceuticals 180
Large-scale testing (Phase 3)Study completedNCT05663827
What this trial is testing

Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease

Who this might be right for
Steroid Refractory GVHD
Yi-Lun Wang 6
Testing effectiveness (Phase 2)Ended earlyNCT02353468
What this trial is testing

Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Plasma Cell Myeloma
University of Colorado, Denver 3
Early research (Phase 1)Study completedNCT01330173
What this trial is testing

Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma+1 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)UnknownNCT00824954
What this trial is testing

Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
University Hospital, Clermont-Ferrand 30
Testing effectiveness (Phase 2)UnknownNCT04677868
What this trial is testing

MTX and Steroid for aGVHD Treatment

Who this might be right for
Acute GVH Disease
Peking University People's Hospital 30
Large-scale testing (Phase 3)Study completedNCT01295710
What this trial is testing

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
GVHDAdult Acute Myeloid LeukemiaAdult Acute Lymphoid Leukemia+1 more
Neovii Biotech 260
Testing effectiveness (Phase 2)Study completedNCT00104858
What this trial is testing

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+6 more
Fred Hutchinson Cancer Center 66
Testing effectiveness (Phase 2)UnknownNCT06087419
What this trial is testing

A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 42
Testing effectiveness (Phase 2)Study completedNCT01034449
What this trial is testing

Transplantation of Ex-vivo Expanded Cord Blood Stems Cells

Who this might be right for
Malignant Haematological Disease
University Hospital, Bordeaux 16
Testing effectiveness (Phase 2)Looking for participantsNCT05664126
What this trial is testing

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Who this might be right for
CytomegalovirusAdenovirus
St. Jude Children's Research Hospital 42
Not applicableNot Yet RecruitingNCT06658938
What this trial is testing

Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
B-ALL
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Ended earlyNCT04002115
What this trial is testing

Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML

Who this might be right for
Acute Myeloid Leukemia
Milton S. Hershey Medical Center 2
Not applicableStudy completedNCT03467074
What this trial is testing

Role of Interferon-λ and Vaccine Response

Who this might be right for
Vaccine Response ImpairedAllogeneic Stem Cell Transplantation
University Hospital, Basel, Switzerland 200
Testing effectiveness (Phase 2)Study completedNCT00052520
What this trial is testing

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+20 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00282282
What this trial is testing

Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseGVHD
Dana-Farber Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03645824
What this trial is testing

Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)

Who this might be right for
Myelofibrosis
Stichting Hemato-Oncologie voor Volwassenen Nederland 61
Next Page